{
  "DOI": "10.1186/s40246-020-00289-x",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-020-00289-x",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eMicroRNAs (miRNAs) play important roles in the regulation of gene expression at the posttranscriptional level and are involved in human carcinogenesis. The aim of the current study was to investigate the associations between \u003cjats:italic\u003emiR-182\u003c/jats:italic\u003e single nucleotide polymorphisms and HCC risk in a southern Chinese population. In this case-control study of 863 HCC patients and 908 cancer-free controls, we performed genotyping of \u003cjats:italic\u003emiR-182\u003c/jats:italic\u003e rs4541843 and assessed its association with HCC risk. We found that individuals carrying the AG/AA genotypes of \u003cjats:italic\u003emiR-182\u003c/jats:italic\u003e rs4541843 were significantly associated with an increased risk of HCC compared with those carrying the GG genotype (adjusted odds ratio (OR) = 1.71, 95% confidence interval (CI) = 1.07–2.76, \u003cjats:italic\u003eP\u003c/jats:italic\u003e = 0.026). In the stratified analysis, this increased risk was more pronounced in the subgroups of older individuals (adjusted OR = 1.98, 95% CI = 1.04–3.76, \u003cjats:italic\u003eP\u003c/jats:italic\u003e = 0.037), males (adjusted OR = 1.81, 95% CI = 1.09–2.99, \u003cjats:italic\u003eP\u003c/jats:italic\u003e = 0.021), and never drinkers (adjusted OR = 1.84, 95% CI = 1.03–3.30, \u003cjats:italic\u003eP\u003c/jats:italic\u003e = 0.041). Our results suggested that \u003cjats:italic\u003emiR-182\u003c/jats:italic\u003e polymorphism rs4541843 may contribute to the susceptibility to HCC. Our findings require validation in further studies with larger sample sizes.\u003c/jats:p\u003e",
  "alternative-id": [
    "289"
  ],
  "article-number": "38",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "28 April 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "6 October 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "15 October 2020"
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Qiu",
      "given": "Moqin",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Liu",
      "given": "Yingchun",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lin",
      "given": "Qiuling",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhou",
      "given": "Zihan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Jiang",
      "given": "Yanji",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Huo",
      "given": "Rongrui",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Liang",
      "given": "Xiumei",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Yu",
      "given": "Xiangyuan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Cao",
      "given": "Ji",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhou",
      "given": "Xianguo",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-9851-2351",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Yu",
      "given": "Hongping",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2020,
        10,
        15
      ]
    ],
    "date-time": "2020-10-15T09:02:47Z",
    "timestamp": 1602752567000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        10,
        14
      ]
    ],
    "date-time": "2021-10-14T23:49:31Z",
    "timestamp": 1634255371000
  },
  "funder": [
    {
      "DOI": "10.13039/501100001809",
      "award": [
        "81660567",
        "81460516"
      ],
      "doi-asserted-by": "publisher",
      "name": "National Natural Science Foundation of China"
    },
    {
      "DOI": "10.13039/501100004607",
      "award": [
        "2018GXNSFDA050012",
        "2015GXNSFCB139007"
      ],
      "doi-asserted-by": "publisher",
      "name": "Natural Science Foundation of Guangxi Province"
    },
    {
      "award": [
        "AB18050020",
        "AA18221001"
      ],
      "name": "Key Research and Development Project of Guangxi"
    },
    {
      "award": [
        "Not applicable"
      ],
      "name": "International Communication of Guangxi Medical University Graduate Education"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2022,
        3,
        31
      ]
    ],
    "date-time": "2022-03-31T21:39:36Z",
    "timestamp": 1648762776097
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2020,
        10,
        15
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2020,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            10,
            15
          ]
        ],
        "date-time": "2020-10-15T00:00:00Z",
        "timestamp": 1602720000000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            10,
            15
          ]
        ],
        "date-time": "2020-10-15T00:00:00Z",
        "timestamp": 1602720000000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-020-00289-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-020-00289-x/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-020-00289-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2020,
        10,
        15
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2020,
        10,
        15
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2020,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.3322/caac.21262",
      "author": "LA Torre",
      "doi-asserted-by": "publisher",
      "first-page": "87",
      "journal-title": "CA Cancer J Clin",
      "key": "289_CR1",
      "unstructured": "Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.",
      "volume": "65",
      "year": "2015"
    },
    {
      "DOI": "10.3322/caac.21492",
      "author": "F Bray",
      "doi-asserted-by": "publisher",
      "first-page": "394",
      "journal-title": "CA Cancer J Clin",
      "key": "289_CR2",
      "unstructured": "Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.",
      "volume": "68",
      "year": "2018"
    },
    {
      "author": "A Villanueva",
      "first-page": "1450",
      "journal-title": "Hepatocellular Carcinoma. N Engl J Med",
      "key": "289_CR3",
      "unstructured": "Villanueva A. Hepatocellular Carcinoma. N Engl J Med. 2019;380:1450–62.",
      "volume": "380",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.soc.2014.09.001",
      "author": "KJ Lafaro",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Surg Oncol Clin N Am",
      "key": "289_CR4",
      "unstructured": "Lafaro KJ, Demirjian AN, Pawlik TM. Epidemiology of hepatocellular carcinoma. Surg Oncol Clin N Am. 2015;24:1–17.",
      "volume": "24",
      "year": "2015"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-17-2537",
      "author": "Y Li",
      "doi-asserted-by": "publisher",
      "first-page": "906",
      "journal-title": "Clin Cancer Res",
      "key": "289_CR5",
      "unstructured": "Li Y, Zhai Y, Song Q, Zhang H, Cao P, Ping J, et al. Genome-Wide Association Study Identifies a New Locus at 7q21.13 Associated with Hepatitis B Virus-Related Hepatocellular Carcinoma. Clin Cancer Res. 2018;24:906–15.",
      "volume": "24",
      "year": "2018"
    },
    {
      "DOI": "10.1038/ng.638",
      "author": "H Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "755",
      "journal-title": "Nat Genet",
      "key": "289_CR6",
      "unstructured": "Zhang H, Zhai Y, Hu Z, Wu C, Qian J, Jia W, et al. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet. 2010;42:755–8.",
      "volume": "42",
      "year": "2010"
    },
    {
      "DOI": "10.1053/j.gastro.2017.01.041",
      "author": "K Matsuura",
      "doi-asserted-by": "publisher",
      "first-page": "1383",
      "journal-title": "Gastroenterology",
      "key": "289_CR7",
      "unstructured": "Matsuura K, Sawai H, Ikeo K, Ogawa S, Iio E, Isogawa M, et al. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection. Gastroenterology. 2017;152:1383–94.",
      "volume": "152",
      "year": "2017"
    },
    {
      "DOI": "10.1002/hep.29531",
      "author": "MH Lee",
      "doi-asserted-by": "publisher",
      "first-page": "651",
      "journal-title": "Hepatology",
      "key": "289_CR8",
      "unstructured": "Lee MH, Huang YH, Chen HY, Khor SS, Chang YH, Lin YJ, et al. Human leukocyte antigen variants and risk of hepatocellular carcinoma modified by hepatitis C virus genotypes: A genome-wide association study. Hepatology. 2018;67:651–61.",
      "volume": "67",
      "year": "2018"
    },
    {
      "DOI": "10.1038/nature02871",
      "author": "V Ambros",
      "doi-asserted-by": "publisher",
      "first-page": "350",
      "journal-title": "Nature",
      "key": "289_CR9",
      "unstructured": "Ambros V. The functions of animal microRNAs. Nature. 2004;431:350–5.",
      "volume": "431",
      "year": "2004"
    },
    {
      "DOI": "10.1016/S0092-8674(04)00045-5",
      "author": "DP Bartel",
      "doi-asserted-by": "publisher",
      "first-page": "281",
      "journal-title": "Cell",
      "key": "289_CR10",
      "unstructured": "Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.",
      "volume": "116",
      "year": "2004"
    },
    {
      "DOI": "10.1111/j.1478-3231.2011.02750.x",
      "author": "J Xu",
      "doi-asserted-by": "publisher",
      "first-page": "752",
      "journal-title": "Liver Int",
      "key": "289_CR11",
      "unstructured": "Xu J, Zhu X, Wu L, Yang R, Yang Z, Wang Q, et al. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/beta-catenin pathway. Liver Int. 2012;32:752–60.",
      "volume": "32",
      "year": "2012"
    },
    {
      "DOI": "10.1002/hep.22749",
      "author": "S Ura",
      "doi-asserted-by": "publisher",
      "first-page": "1098",
      "journal-title": "Hepatology",
      "key": "289_CR12",
      "unstructured": "Ura S, Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, et al. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology. 2009;49:1098–112.",
      "volume": "49",
      "year": "2009"
    },
    {
      "DOI": "10.1038/ncomms12594",
      "author": "BT Woldemichael",
      "doi-asserted-by": "publisher",
      "first-page": "12594",
      "journal-title": "Nature Communications",
      "key": "289_CR13",
      "unstructured": "Woldemichael BT, Jawaid A, Kremer EA, Gaur N, Krol J, Marchais A, et al. The microRNA cluster miR-183/96/182 contributes to long-term memory in a protein phosphatase 1-dependent manner. Nature Communications. 2016;7:12594.",
      "volume": "7",
      "year": "2016"
    },
    {
      "DOI": "10.1186/s13058-014-0473-z",
      "author": "P Li",
      "doi-asserted-by": "publisher",
      "first-page": "473",
      "journal-title": "Breast Cancer Res",
      "key": "289_CR14",
      "unstructured": "Li P, Sheng C, Huang L, Zhang H, Huang L, Cheng Z, et al. MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration. Breast Cancer Res. 2014;16:473.",
      "volume": "16",
      "year": "2014"
    },
    {
      "DOI": "10.1073/pnas.0808263106",
      "author": "MF Segura",
      "doi-asserted-by": "publisher",
      "first-page": "1814",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "289_CR15",
      "unstructured": "Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, Alvarez-Diaz S, et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci U S A. 2009;106:1814–9.",
      "volume": "106",
      "year": "2009"
    },
    {
      "DOI": "10.4149/neo_2016_508",
      "author": "X Wang",
      "doi-asserted-by": "publisher",
      "first-page": "717",
      "journal-title": "Neoplasma",
      "key": "289_CR16",
      "unstructured": "Wang X, Li H, Cui L, Feng J, Fan Q. MicroRNA-182 suppresses clear cell renal cell carcinoma migration and invasion by targeting IGF1R. Neoplasma. 2016;63:717–25.",
      "volume": "63",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s13277-015-3430-2",
      "author": "L Chen",
      "doi-asserted-by": "publisher",
      "first-page": "7439",
      "journal-title": "Tumour Biol",
      "key": "289_CR17",
      "unstructured": "Chen L, Chu F, Cao Y, Shao J, Wang F. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma. Tumour Biol. 2015;36:7439–47.",
      "volume": "36",
      "year": "2015"
    },
    {
      "DOI": "10.1186/1471-2407-12-227",
      "author": "J Wang",
      "doi-asserted-by": "publisher",
      "first-page": "227",
      "journal-title": "BMC cancer",
      "key": "289_CR18",
      "unstructured": "Wang J, Li J, Shen J, Wang C, Yang L, Zhang X. MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma. BMC cancer. 2012;12:227.",
      "volume": "12",
      "year": "2012"
    },
    {
      "DOI": "10.1186/1471-2407-13-19",
      "author": "TY Shi",
      "doi-asserted-by": "publisher",
      "first-page": "19",
      "journal-title": "BMC Cancer",
      "key": "289_CR19",
      "unstructured": "Shi TY, Chen XJ, Zhu ML, Wang MY, He J, Yu KD, et al. A pri-miR-218 variant and risk of cervical carcinoma in Chinese women. BMC Cancer. 2013;13:19.",
      "volume": "13",
      "year": "2013"
    },
    {
      "DOI": "10.1002/ijc.25342",
      "author": "Y Xu",
      "doi-asserted-by": "publisher",
      "first-page": "412",
      "journal-title": "Int J Cancer",
      "key": "289_CR20",
      "unstructured": "Xu Y, Liu L, Liu J, Zhang Y, Zhu J, Chen J, et al. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int J Cancer. 2011;128:412–7.",
      "volume": "128",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.canep.2013.09.005",
      "author": "K Xie",
      "doi-asserted-by": "publisher",
      "first-page": "998",
      "journal-title": "Cancer Epidemiology",
      "key": "289_CR21",
      "unstructured": "Xie K, Liu J, Zhu L, Liu Y, Pan Y, Wen J, et al. A potentially functional polymorphism in the promoter region of let-7 family is associated with survival of hepatocellular carcinoma. Cancer Epidemiology. 2013;37:998–1002.",
      "volume": "37",
      "year": "2013"
    },
    {
      "DOI": "10.1186/s13045-018-0555-y",
      "author": "MQ Cao",
      "doi-asserted-by": "publisher",
      "first-page": "12",
      "journal-title": "J Hematol Oncol",
      "key": "289_CR22",
      "unstructured": "Cao MQ, You AB, Zhu XD, Zhang W, Zhang YY, Zhang SZ, et al. miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a. J Hematol Oncol. 2018;11:12.",
      "volume": "11",
      "year": "2018"
    },
    {
      "DOI": "10.1186/s13046-015-0182-1",
      "author": "C Du",
      "doi-asserted-by": "publisher",
      "first-page": "67",
      "journal-title": "J Exp Clin Cancer Res",
      "key": "289_CR23",
      "unstructured": "Du C, Weng X, Hu W, Lv Z, Xiao H, Ding C, et al. Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma. J Exp Clin Cancer Res. 2015;34:67.",
      "volume": "34",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.gene.2013.12.043",
      "author": "J Qin",
      "doi-asserted-by": "publisher",
      "first-page": "342",
      "journal-title": "Gene",
      "key": "289_CR24",
      "unstructured": "Qin J, Luo M, Qian H, Chen W. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1. Gene. 2014;538:342–7.",
      "volume": "538",
      "year": "2014"
    },
    {
      "DOI": "10.18632/oncotarget.13033",
      "author": "Q Wang",
      "doi-asserted-by": "publisher",
      "first-page": "79365",
      "journal-title": "Oncotarget",
      "key": "289_CR25",
      "unstructured": "Wang Q, Yu X, Li Q, Qin L, Tan S, Zeng X, et al. Association between miR-199a rs74723057 and MET rs1621 polymorphisms and the risk of hepatocellular carcinoma. Oncotarget. 2016;7:79365–71.",
      "volume": "7",
      "year": "2016"
    },
    {
      "DOI": "10.1371/journal.pone.0093707",
      "author": "J An",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS One",
      "key": "289_CR26",
      "unstructured": "An J, Liu J, Liu L, Liu Y, Pan Y, Huang M, et al. A genetic variant in primary miR-378 is associated with risk and prognosis of hepatocellular carcinoma in a Chinese population. PLoS One. 2014;9:e93707.",
      "volume": "9",
      "year": "2014"
    },
    {
      "DOI": "10.1371/journal.pone.0089930",
      "author": "YH Chu",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS One",
      "key": "289_CR27",
      "unstructured": "Chu YH, Hsieh MJ, Chiou HL, Liou YS, Yang CC, Yang SF, et al. MicroRNA gene polymorphisms and environmental factors increase patient susceptibility to hepatocellular carcinoma. PLoS One. 2014;9:e89930.",
      "volume": "9",
      "year": "2014"
    },
    {
      "DOI": "10.1093/carcin/bgn195",
      "author": "T Xu",
      "doi-asserted-by": "publisher",
      "first-page": "2126",
      "journal-title": "Carcinogenesis",
      "key": "289_CR28",
      "unstructured": "Xu T, Zhu Y, Wei QK, Yuan Y, Zhou F, Ge YY, et al. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis. 2008;29:2126–31.",
      "volume": "29",
      "year": "2008"
    },
    {
      "DOI": "10.1371/journal.pone.0032230",
      "author": "Y Liu",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS One",
      "key": "289_CR29",
      "unstructured": "Liu Y, Zhang Y, Wen J, Liu L, Zhai X, Liu J, et al. A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma. PLoS One. 2012;7:e32230.",
      "volume": "7",
      "year": "2012"
    },
    {
      "DOI": "10.1155/2018/1540201",
      "author": "C Bei",
      "doi-asserted-by": "publisher",
      "first-page": "1540201",
      "journal-title": "Biomed Res Int",
      "key": "289_CR30",
      "unstructured": "Bei C, Liu S, Yu X, Qiu M, Tang B, Liao W, et al. Single Nucleotide Polymorphisms in miR-122 Are Associated with the Risk of Hepatocellular Carcinoma in a Southern Chinese Population. Biomed Res Int. 2018;2018:1540201.",
      "volume": "2018",
      "year": "2018"
    }
  ],
  "reference-count": 30,
  "references-count": 30,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-020-00289-x"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "A miR-182 variant and risk of hepatocellular carcinoma in a southern Chinese population"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "14"
}